These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 37919031
21. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis. Saghazadeh A, Rezaei N. J Interferon Cytokine Res; 2022 Mar; 42(3):95-107. PubMed ID: 35298290 [Abstract] [Full Text] [Related]
22. A Simple Microfluidic Assay for Diagnosing Tuberculous Meningitis in HIV-Uninfected Patients. Park JH, Jin CE, Koo B, Kwon JS, Cha HH, Kim JY, Noh GS, Koo YS, Jeon SB, Lee SA, Shin Y, Kim SH. J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814264 [Abstract] [Full Text] [Related]
23. Prognostic value of computed tomography-evident cerebral infarcts in adult patients with tuberculous meningitis and hydrocephalus treated with an external ventricular drain. Clemente Morgado T, Kinsky M, Carrara H, Rothemeyer S, Semple P. World Neurosurg; 2013 Dec; 80(6):e255-60. PubMed ID: 23041069 [Abstract] [Full Text] [Related]
25. Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients. Park KH, Lee MS, Kim SM, Park SJ, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kang JK, Lee SA, Kim SH. J Infect; 2016 Apr; 72(4):486-97. PubMed ID: 26851800 [Abstract] [Full Text] [Related]
26. Advances in the diagnosis and treatment of tuberculous meningitis. Thwaites GE. Curr Opin Neurol; 2013 Jun; 26(3):295-300. PubMed ID: 23493162 [Abstract] [Full Text] [Related]
27. Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis. Nuwagira E, Huppler Hullsiek K, Jjunju S, Rutakingirwa M, Kasibante J, Tadeo KK, Kagimu E, Tugume L, Ssebambulidde K, Musubire AK, Bangdiwala A, Muzoora C, Meya DB, Boulware DR, Bahr NC, Creswell FV. Microbiol Spectr; 2022 Aug 31; 10(4):e0161822. PubMed ID: 35727068 [Abstract] [Full Text] [Related]
28. Tuberculous meningitis in patients infected with human immunodeficiency virus. Garg RK, Sinha MK. J Neurol; 2011 Jan 31; 258(1):3-13. PubMed ID: 20848123 [Abstract] [Full Text] [Related]
29. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Marais S, Meintjes G, Pepper DJ, Dodd LE, Schutz C, Ismail Z, Wilkinson KA, Wilkinson RJ. Clin Infect Dis; 2013 Feb 31; 56(3):450-60. PubMed ID: 23097584 [Abstract] [Full Text] [Related]
30. Cognitive Impairment in Tuberculous Meningitis. Davis AG, Dreyer AJ, Albertyn C, Maxebengula M, Stek C, Wasserman S, Marais S, Bateman K, Solms M, Joska J, Wilkinson RJ, Nightingale S. Clin Infect Dis; 2023 Mar 04; 76(5):842-849. PubMed ID: 36262054 [Abstract] [Full Text] [Related]
33. Role of cerebrospinal fluid shunting for human immunodeficiency virus-positive patients with tuberculous meningitis and hydrocephalus. Nadvi SS, Nathoo N, Annamalai K, van Dellen JR, Bhigjee AI. Neurosurgery; 2000 Sep 04; 47(3):644-9; discussion 649-50. PubMed ID: 10981752 [Abstract] [Full Text] [Related]
34. Diagnosis of tuberculous meningitis: challenges and promises. Philip N, William T, John DV. Malays J Pathol; 2015 Apr 04; 37(1):1-9. PubMed ID: 25890607 [Abstract] [Full Text] [Related]
35. mRNA profiling of cytokines to understand paradoxical response in HIV-uninfected tuberculous meningitis. Kalita J, Shukla R, Pandey PC, Singh V, Haldar R, Misra UK. Tuberculosis (Edinb); 2024 Jan 04; 144():102463. PubMed ID: 38101267 [Abstract] [Full Text] [Related]
36. Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: A case report. Liu P, Pei N, Liu X, Huang W, Lu S. Medicine (Baltimore); 2020 Oct 02; 99(40):e22639. PubMed ID: 33019487 [Abstract] [Full Text] [Related]
37. Human immunodeficiency virus in patients with tuberculous meningitis: systematic review and meta-analysis. Pormohammad A, Nasiri MJ, Riahi SM, Fallah F. Trop Med Int Health; 2018 Jun 02; 23(6):589-595. PubMed ID: 29660820 [Abstract] [Full Text] [Related]
38. Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia. Nataprawira HM, Gafar F, Risan NA, Wulandari DA, Sudarwati S, Marais BJ, Stevens J, Alffenaar JC, Ruslami R. Emerg Infect Dis; 2022 Mar 02; 28(3):660-671. PubMed ID: 35202524 [Abstract] [Full Text] [Related]
39. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. Qu J, Zhou T, Zhong C, Deng R, Lü X. BMC Infect Dis; 2017 Jan 10; 17(1):51. PubMed ID: 28068915 [Abstract] [Full Text] [Related]
40. The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Seddon JA, Tugume L, Solomons R, Prasad K, Bahr NC, Tuberculous Meningitis International Research Consortium. Wellcome Open Res; 2019 Jan 10; 4():167. PubMed ID: 32118118 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]